Navigation Links
Biocon Net Profit Up by 15 Percent for Fiscal Year

Indian biotechnology major Biocon Ltd. Thursday announced a 15 percent surge in its profit at Rs.2 billion with a total income at Rs.9.9 billion in fiscal 2006-07. //

The firm's expenditure on research and development, during 2006-07, also increased by 86 percent at Rs.380 million, it said in a statement. It also announced increase in dividend from 50 to 60 percent, with Rs.3 per share, as recommended by the court.

"Our strategy of building global scale in our products and services businesses has delivered robust profits this fiscal year. This has enabled us to invest incrementally in our innovation led research programmes which will deliver attractive shareholder returns in the coming years," said Kiran Mazumdar-Shaw, chairman and managing director, Biocon Ltd.

"Today, Biocon and its subsidiaries have created a unique matrix of capabilities that has earned us a strong reputation as a preferred partner to global pharma and biotech companies," she added.

The company's subsidiary Syngene, during this period, entered into a partnership with Bristol Myers Squibb one of the world's leading pharmaceutical firms, to provide research and development (R&D) services for development of drugs.

"In the year ahead, we will continue to make significant investments to progress our innovation pipeline and leverage upon the strategic initiatives taken to enter into new business segments like oncology and nephrology whilst continuing to expand our cardio-diabetes reach globally," said Biocon's chief operating officer Arun Chandavarkar.

Source-IANS/L
'"/>




Page: 1

Related medicine news :

1. Biocon to colloborate for development of Oral peptide drugs for heart diseases.
2. Biocon To Raise Its Investment In Scotland
3. Biocon To Shift Focus On Innovation To Accelerate Growth
4. Kalam Dedicates New Cancer Drug Developed By Biocon
5. Bayer to Market Biocon Insulin in China
6. Biocon Launches Anti-Cancer Drug
7. Biocon to Launch Anti-arthritis Drug
8. Biocon Unveils Renal Therapies for Kidney Disorders
9. Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs
10. Premature Babies Profit From Caffeine Therapy
11. 45 Percent Of Errors In Cancer Diagnosis Harm The Patient
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... , ... April 21, 2017 , ... Providing broad access ... in opposition, but there is a better way to address this problem. , That ... of Pharmacy, Public Policy and Economics at the University of Southern California, who served ...
(Date:4/21/2017)... ... , ... Brady (NYSE:BRC), a global leader in industrial and safety ... vinyl label materials received certification for the BS5609 British Marine Standard. This internationally ... legible, for use on chemical drums shipped by sea. , “Achieving BS5609 ...
(Date:4/21/2017)... ... April 21, 2017 , ... The VIA Agency , ... for Theravent, Inc. , the makers of a revolutionary new device clinically ... is now working to expand distribution in anticipation of a national launch. VIA ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a home ... of Utah (APCUT) and has appointed Rex Wheeler as its new Director of Business ... our agency and our ability to provide quality care to the community,” said Tammara ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: